Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes

Author： Li Na Abe Shinya Kurata Morito Abe-Suzuki Shiho Onishi Iichiroh Kirimura Susumu Murayama Toshihiko Hidaka Michihiro Kawano Fumio Kitagawa Masanobu

Publisher： Springer Publishing Company

ISSN： 1219-4956

Source： Pathology & Oncology Research, Vol.20, Iss.2, 2014-04, pp. : 399-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Overexpression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes

By He Qi Li Xiao Zhang Zheng Zhang Qianqiao Xu Feng Yang Lianping Tao Ying Liu Yizhi

Cancer Investigation, Vol. 28, Iss. 10, 2010-11 ,pp. : 983-988

Informa Healthcare

Access to resources Recommend Favorite

Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3228-3232

Spandidos Publications

Access to resources Recommend Favorite

Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes

By Ueda Yasunori

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1450-1458

Informa Healthcare

Access to resources Recommend Favorite

Artesunate-enhanced apoptosis of human high-risk myelodysplastic cells induced by the DNA methyltransferase inhibitor decitabine

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2449-2454

Spandidos Publications

Access to resources Recommend Favorite

Effect of DLK1 on tumorigenesis in CD34+CD38- bone marrow cells in myelodysplastic syndromes

By Zhang Wei Shao Zonghong Fu Rong Wang Huaquan Li Lijuan Yue Lanzhu

Oncology Letters, Vol. 6, Iss. 1, 2013-07 ,pp. : 203-206

Spandidos Publications

Access to resources Recommend Favorite